MECHANISMS OF CARDIOPROTECTIVE EFFECTS OF DESFLURANE AND SEVOFLURANE DURING REPERFUSION

Authors

  • Tashkenbaeva Eleonora Negmatovna
  • Nasyrova Zarina Akbarovna
  • Saidov Maksud Arifovich
  • Yusupova Mokhinabonu Farrukhovna
  • Boltakulova Sarvinoz Dilshodovna

Keywords:

desflurane, sevoflurane, reperfusion, postconditioning, preconditioning, reperfusion injury, extracorporeal circulation

Abstract

Myocardial conditioning is actually an important strategy in the management of ischemic reperfusion injury. The concept of postconditioning anesthetic is intriguing, its action occurs at a key moment (reperfusion, when ischemic reperfusion lesions are initiated), when activation of these cardioprotective mechanisms can overpower the mechanisms leading to ischemic reperfusion injuries. Desflurane and sevoflurane are volatile anesthetics often used during cardiac surgery. This review focuses on the efficacy of desflurane and sevoflurane administered during early reperfusion as a potential cardioprotective strategy. The mechanisms underlying the cardioprotective action of these agents and their ability to induce postconditioning have been discussed in detail, highlighting the role of reactive oxygen species generation, activation of cellular signaling pathways, and action on mitochondria. This may well be enough to revive the basis for the launch of the randomized clinical trials that are really needed to confirm that this strategy has real impact.

References

A Araszkiewicz, M Grygier, M Pyda, J Rajewska, M Lesiak, S Grajek

Postconditioning attenuates early ventricular arrhythmias in patients with high-risk ST-segment elevation myocardial infarction. J Cardiol, 65 (2015), pp. 459-465

A Khan, A Binabdulhak, Y Alastal, et al. Cardioprotective role of ischemic post-conditioning in acute myocardial infarction : a systematic review and meta-analysis

Am Hear J, 168 (2014), pp. 512-521

A Zangrillo, V Testa, V Aldrovandi, et al. Volatile agents for cardiac protection in noncardiac surgery: a randomized controlled study. J Cardiothorac Vasc Anesth, 25 (2015), pp. 902-907

C Kikuchi, S Dosenovic, M Bienengraeber Anaesthetics as cardioprotectants - translatability and mechanism Br J Pharmacol, 172 (2015), pp. 2051-2061

D Obal, S Dettwiler, C Favoccia, H Scharbatke, B Preckel, W Schlack

The influence of mitochondrial KATP-channels in the cardio-protection of preconditioning and post-conditioning by sevoflurane in the rat in vivo Anesth Analg, 101 (2005), pp. 1252-1260

J Zhang, C Wang, S Yu, et al. Sevoflurane post-conditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3 K/AKT/mTOR signalling

Sci Rep, 4 (2014), p. 7317

JL Guerrero Orriach, MG Ortega, MR Aliaga, P Iglesias, MR Navarro, J Mañas

Prolonged sevoflurane administration in the off-pump coronary artery bypass graft surgery: beneficial effects. J Crit Care, 879 (2013), pp. e13-e18

J Hellström, A Öwall, CR Martling, P Sackey. Inhaled Isoflurane Sedation During Therapeutic Hypothermia After Cardiac Arrest: A Case Series Crit Care Med, 42 (2014), pp. 161-166

G Landoni, F Guarracino, C Cariello, et al. Volatile compared with total intravenous anaesthesia in patients undergoing high-risk cardiac surgery: a randomized multicentre study. Br J Anaesth, 113 (2014), pp. 955-963

KA Kortekaas, A van der Baan, LP Aarts, et al. Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repair. Br J Anaesth, 112 (2014), pp. 1005-1014

MV Cohen, JM Downey Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered. J Cardiovasc Pharmacol Ther, 19 (2014), pp. 179-190

M Zaugg, E Lucchinetti Letter by Zaugg and Lucchinetti regarding article, “Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery”. Circulation, 127 (2013), pp. e875-e876

N Jivraj, F Liew, M Marber Ischaemic post-conditioning: cardiac protection after the event

Anaesthesia, 70 (2015), pp. 598-612

SG De Hert, PJ Van der Linden, S Cromheecke, et al. Cardioprotective Properties of Sevoflurane in Patients Undergoing Coronary Surgery with Cardiopulmonary Bypass Are Related to the Modalities of Its Administration Anesthesiology, 101 (2004), pp. 299-310

S Lemoine, L Zhu, G Beauchef, et al. Signaling pathways involved in desflurane-induced post-conditioning in human atrial myocardium in vitro. Anesthesiology, 109 (2008), pp. 1036-1044

ZQ Zhao, JS Corvera, ME Halkos, et al.

Inhibition of myocardial injury by ischemic post-conditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol, 285 (2003), pp. H579-H588

YL Zhang, YT Yao, NX Fang, CH Zhou, JS Gong, LH Li Restoration of autophagic flux in myocardial tissues is required for cardio-protection of sevoflurane post-conditioning in rats. Acta Pharmacol Sin, 35 (2014), pp. 758-769

V Barsukevich, M Basalay, J Sanchez, et al. Distinct cardio-protective mechanisms of immediate, early and delayed ischaemic post-conditioning Basic Res Cardiol, 110 (2015), p. 452

YT Yao, DH Liu, LH Li Comparison of cardio-protective effects induced by different modalities of sevoflurane conditioning in isolated rat hearts. Perfusion (2015)

Advance Access published on June 9, pii: 0267659115590833

Published

2021-07-23